Please login to the form below
schools
This page shows the latest schools news and features for those working in and with pharma, biotech and healthcare.
Biogen's ALS drug tofersen misses phase 3 endpoint
VALOR principal investigator Dr Timothy Miller from the ALS Center at Washington University School of Medicine, St Louis, said: “The wait for new options has been long and difficult for the
Latest news
-
The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines
One panel member, professor of paediatrics at Harvard Medical School, Ofer Levy, urged action.
-
FDA approves Eli Lilly’s Verzenio in high risk early breast cancer
Tolaney, Harvard Medical School, Dana-Farber Cancer Institute, and investigator on the monarchE study.
-
World Mental Health Day is on 10 October
More proactive mental health support within medical schools and hospitals. Greater awareness of mental health support for doctors in hospitals. ... In a survey of 154 healthcare professionals and medical school students conducted by.
-
FDA acting commissioner Janet Woodcock requests independent review of Aduhelm approval
Since Aduhelm's approval, three members of that panel have resigned, including Aaron Kesselheim, a professor of medicine at Harvard Medical School, who said the authorisation “was probably the worst drug
-
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
Since the approval, three members of that panel have resigned, including Aaron Kesselheim, a professor of medicine at Harvard Medical School, who said the authorisation “was probably the worst drug approval
The FDA vaccine advisory board recommends booster shots of both the J&J and Moderna vaccines
FDA approves Eli Lilly’s Verzenio in high risk early breast cancer
World Mental Health Day is on 10 October
FDA acting commissioner Janet Woodcock requests independent review of Aduhelm approval
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
More from news
Approximately 2 fully matching, plus 629 partially matching documents found.
Latest Intelligence
-
Straight outta lockdown – what’s next for flexible working?
deadlines with additional responsibilities, while full-time colleagues often feel burdened by additional last-minute deadlines that land after their colleagues have gone on the school run.
-
The future of work has been just around the corner for some time...
we provided 150 laptops to schools. Our well-established Dynamic Flexible Working policy allowed our people to transition to permanent homeworking immediately,.
-
Rare diseases: why they can be so difficult to identify
The patient’s HCPs may not have studied such disorders extensively during their medical training – or perhaps it was called something else when they were in medical school. ... The phrase, ‘When you hear hoofbeats, think horses, not zebras’, was
-
Why female mentorship is so powerful in pharma
They hear about other women’s experiences moving across the world for a tour of duty, taking stretch assignments, going back to school or planning maternity leave.
-
The promise of precision medicine
A significant effort will be required from health industry bodies, governments and medical schools to train workers so that they can perform the tasks that will be needed to fully exploit
Straight outta lockdown – what’s next for flexible working?
The future of work has been just around the corner for some time...
Rare diseases: why they can be so difficult to identify
Why female mentorship is so powerful in pharma
The promise of precision medicine
More from intelligence
Approximately 0 fully matching, plus 89 partially matching documents found.
Latest appointments
-
Merck’s CEO Kenneth Frazier to retire after ten years in the role
from Columbia Business School and more.
-
Ashfield appoints new global head of quality and compliance
She also attended Rutgers University School of Law, and is a member of both the Pennsylvania and New Jersey Bar Associations and the Healthcare Compliance Association.
-
Porterhouse announces members of medical advisory group
She graduated from St Bartholomew’s and the London School of Medicine and Dentistry in 2001, working as a pathologist in the NHS until 2015.
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors
Horning received her MD from University of Iowa School of Medicine, and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University.
-
Health comms agency emotive hires new cell and gene therapy leader
She completed her post-doctoral training at Harvard Medical School and has spent over eight years working across a broad variety of research, regulatory, quality assurance and medical writing roles at
Merck’s CEO Kenneth Frazier to retire after ten years in the role
Ashfield appoints new global head of quality and compliance
Porterhouse announces members of medical advisory group
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors
Health comms agency emotive hires new cell and gene therapy leader
More from appointments
Approximately 0 fully matching, plus 43 partially matching documents found.
Latest from PMHub
-
Day in the life of an emotive Art Director
I would say my high school art teacher. I’ve made art my career and she wasn’t the last person to encourage me to do so. .
-
Three amazing women at emotive talk about what they love about medical communications
Dr Silvana Bardelli, Senior Medical Writer, has a PhD in human molecular genetics and completed her post-doctoral research at Harvard Medical School.
-
Genetic Digital
Clinics &medical practices. Doctors, consultants &surgeons. University medical schools.
-
Another Landmark Lucid Workiversary
My fascination with science started at school – I have always read a lot about the sciences and enjoy the journey of discovery.
-
Numbers, navigation, and narratives: digital storytelling in medical communications
Since the 1980s, American medical schools and hospitals have promoted so‑called narrative medicine in healthcare curricula to facilitate reflection and reduce the distance between technical understanding of the disease and
Genetic Digital
More from PMHub
Approximately 2 fully matching, plus 114 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Biogen's ALS drug tofersen misses phase 3 endpoint
- Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Valneva COVID-19 vaccine more effective than AZ
- Real-world data highlights flu vaccine efficacy
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- Best practice in UK diabetes care recognised at prestigious national awards
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Beyond yoga and smoothies – providing real support for employee well-being
- The Future of eHealth: Contactless Health Monitoring
- How do you define a biotech company?
- Attracting the best talent to build Lucid’s future
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
